Clinical Trials

The James Cancer Center Columbus, OH

open for enrollment

Ph III, Atezolizumab Vs Placebo In Comb W/ Paclitaxel, Carboplatin, And Bevacizumab

Protocol: OSU-17036

Full Title

A Phase III, Multicenter, Randomized, Study Of Atezolizumab Versus Placebo Administered In Combination With Paclitaxel, Carboplatin, And Bevacizumab To Patients With Newly-Diagnosed Stage III Or Stage IV Ovarian, Fallopian Tube, Or Primary Peritoneal Cancer

Gynecologic Cancers Ovarian Cancer